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ABSTRACT
The Cu+ pump ATP7B plays an irreplaceable role in the elimination of
excess Cu+ by the hepatocyte into the bile. The trafficking and site of
action of ATP7B are subjects of controversy. One current proposal
is that an increase in intracellular Cu+ results in the translocation of
ATP7B to the lysosomes and excretion of excess Cu+ through
lysosomal-mediated exocytosis at the bile canaliculus. Here, we
show that ATP7B is transported from the trans-Golgi network (TGN)
to the bile canaliculus by basolateral sorting and endocytosis,
and microtubule-mediated transcytosis through the subapical
compartment. Trafficking ATP7B is not incorporated into lysosomes,
and addition of Cu+ does not cause relocalization of lysosomes and the
appearance of lysosome markers in the bile canaliculus. Our data
reveal the pathway of the Cu+-mediated transport of ATP7B from the
TGN to the bile canaliculus and indicates that the bile canaliculus is the
primary site of ATP7B action in the elimination of excess Cu+.
KEY WORDS: Copper, ATP7B, Trafficking, TGN, Bile canaliculus,
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INTRODUCTION
The redox properties of Cu+ endow the metal with the simultaneous
ability to be both essential and potentially damaging to the cell.
Thus, as the cell only needs Cu+ in trace amounts, to counter the
relative high levels of Cu+ in food, animals have developed
sophisticated mechanisms to chaperone, store and eliminate excess
Cu+. In the liver, hepatocytes act as the major captor of the Cu+
absorbed in the digestive tract, the main reservoir and distributor of
Cu+ to other tissues and organs, as well as the key mediator of Cu+
elimination through excretion into bile (Harris, 2000; Lalioti et al.,
2009). Because of these three functionalities, the liver plays an
essential role in Cu+ homeostasis in mammals, birds and reptiles.
In the hepatocyte, the elimination of Cu+ is mediated by ATP7B,
a membrane pump specialized for the vectorial transport of Cu+
(Bull et al., 1993; Tanzi et al., 1993). At physiological
concentrations of Cu+, ATP7B is localized to the trans-Golgi
network (TGN), where it functions in the transfer of Cu+ to
secretory proteins, such as ceruloplasmin. Increased Cu+ levels in
the hepatocyte result in the release of the ATP7B that has been
sequestered in the trans-Golgi network (TGN) and its relocation to
other membrane compartments. However, although the direct
relocalization of ATP7B to the bile canaliculus would appear to
be the most likely trafficking route, studies on the Cu+-induced
relocation of ATP7B have resulted in identification of other
membrane targets, including late endosomes and lysosomes
(Harada et al., 2003a; Polishchuk et al., 2014; Weiss et al., 2008).
In addition, a stable pool of ATP7B has been located at tight
junctions (Hernandez et al., 2008). The detection of Cu+ within
lysosomes carrying ATP7B in their membranes and the increase in
trafficking of ATP7B to the bile canaliculus upon activation of
lysosomal exocytosis, together with the recent report that brief
exposure to Cu+ activates lysosomal exocytosis, has led to the
proposal that ATP7B pumps excess Cu+ into lysosomes and that the
lysosomes loaded with Cu+ then fuse with the membrane of the bile
canaliculus (Polishchuk et al., 2014). These observations are in
contrast with studies indicating that ATP7B is transported from the
Golgi to the bile canaliculus (Guo et al., 2005; Hernandez et al.,
2008; Roelofsen et al., 2000) and recent evidence indicating that
transport to the bile canaliculus occurs through a trans-endosomal
pathway (Lalioti et al., 2014; Nyasae et al., 2014).
Although more than 300 mutations in the ATP7B gene that affect
the function and cellular distribution of ATP7B have been
associated with Wilson disease – a rare autosomal Cu+ toxicosis
(Kenney and Cox, 2007) – the tight association between the
trafficking and function of ATP7B in Cu+ donation and elimination
makes it likely that some Cu+ metabolism abnormalities are caused
by dysfunction of membrane protein trafficking and regulation,
which might also affect the distribution of other proteins. With
regard to this, it is interesting that mutation of the AP1S1 gene,
which codes for the σ1A subunit of the clathrin adaptor AP-1 that is
involved in the intracellular trafficking of Cu+ transporters ATP7B
and ATP7A (Holloway et al., 2013; Jain et al., 2015; Lalioti et al.,
2014), causes MEDNIK syndrome, which includes a disorder in
Cu+ homeostasis (Martinelli et al., 2013). Furthermore, deficiency
of COMMD1, a protein component of the COMMD–CCDC22–
CCDC93 (CCC) complex that plays an important role in the
trafficking of retromer cargo, results in defective Cu+ homeostasis
(Phillips-Krawczak et al., 2015; van De Sluis et al., 2002).
It is thus important to characterize the trafficking pathway of
ATP7B in the hepatocyte and the site of ATP7B action, not only to
enable the identification of the genetic defects associated with Cu+
toxicosis, but also to understand the presentation and course of those
disorders, and to design specific strategies to prevent and treat them.
We describe here the characterization of the Cu+-dependent
pathway of ATP7B translocation from the TGN to the bile
canaliculus in the polarized rat hepatoma Can 10 cell line. Our
results indicate that upon Cu+-induced release from the trans-Golgi
network, ATP7B is initially sorted to the basolateral membrane
and then transported by transcytosis to the bile canaliculus via aReceived 10 December 2015; Accepted 28 March 2016
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route that includes the subapical compartment and excludes the
lysosomes.
RESULTS
Polarized hepatoma Can 10 cells use the inwards-positioned apical
surface to assemble bile canaliculi of different sizes and, when
growing in small islets, arrange their bodies perpendicular to the bile
canaliculus and project their large basolateral surface outwards (Fig.
S1A–D) (Cassio et al., 2007; Hernandez et al., 2008); this
arrangement greatly facilitates monitoring the changes in the
distribution of ATP7B in response to increased Cu+ levels in the cell.
ATP7B is sorted basolaterally at the TGN by acidic vesicles
Careful titration of the Cu+-dose–ATP7B-response in Can 10 cells
showed that additions of Cu+ of >1 µM to the cell medium caused the
mobilization of the ATP7B that was retained in the TGN at low Cu+
concentrations. To study the pathway of ATP7B translocation from
the TGN to the bile canaliculus, we used 40 µMCu+ – a concentration
that causes the fast release of ATP7B from the TGN and a trafficking
rate that is suitable formonitoring the redistribution ofATP7B and for
characterization of the transport pathway.
ATP7B began to leave the TGN within 5 min after addition of
Cu+, and the release was completed in 15–20 min (Fig. 1A1–C2).
The acidic pH of the TGN led us to study whether an increase in the
pH affects the ATP7B release. To this end, we studied the release of
ATP7B from the TGN in Can 10 cells that had been preincubated for
3 h with 50 µM chloroquine, an acidotropic agent that accumulates
in acidic organelles, resulting in loss of acidity and osmotic
swelling. The study revealed that 15 min after the addition of Cu+,
many of the vesicles transporting ATP7B out of the Golgi remained
attached to the TGN and were swollen, hence indicating that the
acidity of the TGN is crucial for the release of the vesicles loaded
with ATP7B (Fig. 1D1).
Because V-type H+ ATPase inhibitors are essential for organelle
acidification, and because deacidification byspecific inhibitors blocks
TGN to plasma membrane delivery (Yilla et al., 1993), we next
studied the effect of bafilomycinA1 on the release ofATP7B from the
TGN. In cells that had been treated for 3 h with 100 nM bafilomycin
A1andwas thenchallenged for 15and25 minwithCu+,we found that
the drug caused the segregation of the cisterna that had the appearance
of ‘bunches of grapes’ and was loaded with ATP7B from the cisterna
hosting the TGN marker TGN38 (Fig. 1E–G) before the ‘grape’-like
cisterna broke into clusters of EEA1-positive-endosomes (Fig. 1H)
(see Discussion). The rapid incorporation of the early endosome
markerEEA1 into thevesicle clusters that originate from theGolgi had
been observed in cells transfected with ATP7Bmutants (Lalioti et al.,
2014), and might explain the localization of ATP7B in clusters of
basolateral endosomes in cells that were treated with bafilomycin A1
(Nyasae et al., 2014) (see Discussion).
Remarkably, much of the ATP7B released from the TGN in cells
incubated for 5–10 min with Cu+ was found in vesicle-like
structures hoarded at the far end of the basolateral domain,
opposite to the apical bile canaliculus (Fig. 2A–B2), and many of
those vesicles retained the EEA1 marker (Fig. S1E–G). Next, to
study the presence of ATP7B in basolateral endosomes, we
incubated the cells for 12 min with Cu+ and, for the last 8 min of
the incubation, with the marker of basolateral endocytosis Alexa-
Fluor-647–transferrin. The detection of transferrin in vesicles
loaded with ATP7B at the far end of the basolateral domain,
opposite to the bile canaliculus, was consistent with the transport of
ATP7B through basolateral endosomes after its release from the
TGN (Fig. 2C1–C3; Table S1).
Basolaterally sorted ATP7B is not incorporated into
lysosomes
The acidity of the vesicles loaded with ATP7B that pinch-off
from the TGN and the reported ability of Cu+ to induce the direct
and fast incorporation of ATP7B into late endosomes and/or
lysosomes (Polishchuk et al., 2014) prompted us to examine
those vesicles and the incorporation of ATP7B into lysosomes
during ATP7B relocation to basolateral endosomes. To this end,
and to minimize the chances that ATP7B would be incorporated
into a discrete or small population of lysosomes, causing the
event to pass unnoticed, we compared separately the distributions of
ATP7B and four lysosomal integral membrane proteins (LIMPs) –
CD63, LIMPII, LAMP1 and LAMP2 – that are unevenly distributed
among late endosomes, plasma membrane, specialized phagosomes
and secretory vesicles (Fig. 3A) (Barriocanal et al., 1986;
Metzelaar et al., 1992). Two of these proteins, CD63 and
LAMP1, have been used in the study that described the Cu+-
induced incorporation of ATP7B into lysosomes of HepG2 cells
(Polishchuk et al., 2014).
The possible incorporation of ATP7B into lysosomes and of
LIMPs into ATP7B vesicular carriers was next studied by
comparing separately the distributions of ATP7B and the
LIMPs CD63, LIMP II and LAMP2 in cells that had been treated
for 15 min with Cu+ in order to induce the bulk of ATP7B to move
through the basolateral domain (Fig. 3B1–B6,C1,D1,E1). Under
these conditions, the average ATP7B:LIMPs coincidence ratio in
ATP7B vesicles and lysosomes was never higher than 0.0206:1
(Table S2). Furthermore, using the non-parametric Kolmogorov and
Wilcoxon tests (Tables S4 and S5) to analyze the non-normal
distribution of pairs of the CD63, LIMP II and LAMP1 populations
(Fig. S3A, Table S3), we found that the association of ATP7B
and LIMPs in ATP7B-positive vesicular carriers and lysosomes
can be described by the two separate populations CD63 and
LIMPII–LAMPI, with intervals of confidence of [4.156×10−3,
8.861×10−3]/[1.315×10−2, 2.082×10−2] and [3.247×10−3,
6.93×10−3]/[1.153×10−2, 1.886×10−2], respectively (Table S6).
These intervals reaffirmed the calculated ATP7B:LIMPs
coincidence ratio lower than 0.0206:1, a value that fell
dramatically short of the 0.40:1 ratio reported in HepG2 cells
(Polishchuk et al., 2014). Altogether, these data indicate that the
vesicles that transport ATP7B through the basolateral domain are
structures that are distinct from lysosomes.
ATP7B is inserted into the basolateral membrane and
endocytosed
To identify whether the presence of ATP7B in basolateral
endosomes resulted from the fusion of endosomes with the
vesicles that transported ATP7B to the basolateral domain, or
from the ATP7B insertion into the basolateral membrane and
subsequent endocytosis, we studied the effect of dynasore (DYN),
the inhibitor of dynamin and clathrin-dependent endocytosis. We
repeated the transferrin-loading experiment in cells that had been
transfected with exofacial hemagglutinin (HA)-tagged ATP7B,
followed by simultaneous incubation of the cells with Alexa-Fluor-
647–transferrin and an antibody against HA. Treatment of cells for
60 min with DYN before challenge with Cu+ showed a marked
retention of ATP7B in the basolateral surface and a complete
inhibition of its incorporation into the bile canaliculi, an effect that
was strongly reversed after washing out the drug (compare
Fig. 4A1–A3 and 4B1–B3). Moreover, in cells that had been
transfected with HA–ATP7B, we located the endocytosed HA tag
and Alexa-Fluor-647–transferrin in endosomes transporting ATP7B
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(Fig. 4C1–C3). These two studies strongly indicate that, after its
release from the TGN, ATP7B is targeted to the basolateral domain
and inserted into the basolateral membrane, and is then
endocytosed.
To investigate whether ATP7B interacts with AP-2, the
clathrin adaptor complex that participates in clathrin-mediated
endocytosis of cargo, we examined the ability of ATP7B and the
α subunit of the AP-2 adaptor to pull each other down in
inmunoprecipitation assays (Fig. 4D). Confirmation of this ability
indicates that the surface-localized AP-2 might participate in
the clathrin-mediated endocytosis of ATP7B that is inhibited
with DYN.
ATP7B is vectorially transported from the basolateral to the
apical domain by a mechanism that requires microtubules
To examine the redistribution of the basolateral endosomes loaded
with ATP7B and transferrin, we extended the treatment of cells with
Cu+ to 25 min and postponed the addition of transferrin to the last
10 min of incubation with Cu+ (Fig. 2D1–D3). Under these
conditions, ATP7B began to appear in the apical pole of the cells
and to dissociate from basolateral endosomes loaded with
transferrin (compare Fig. 2C and 2D; Table S1). It is well
established that vesicle-mediated transcytosis from the basolateral
to the apical domain requires microtubules (Hunziker et al., 1990).
To explore whether transport of ATP7B to the apical pole requires
Fig. 1. ATP7B is quickly released from the TGN in response to Cu+. Can 10 cells were treated with 40 µM Cu+ for the indicated times and immunostained for
ATP7B and the TGNmarker TGN38 (A1–C2); w/o, untreated controls. ATP7B is transported out of the TGN by acidic vesicles: chloroquine (CQ) induces swelling
and retards the release of ATP7B-loaded vesicles emerging from the TGN upon Cu+ stimulation. Can 10 cells that had been treated for 3 h with 50 µM chloroquine
followed by 15 min with 40 µMCu+ + cloroquinewere stained for ATP7B and the lysosomal integral membrane protein LAMP1. Confocal microscopy of a 0.04-µm
optical section was then performed (D1,D2). The intense fluorescence produced by the ATP7B was retained in the vesiculated TGN and in swollen vesicles
attached to the TGN that are distinct from the lysosomes. Inhibition of the V-H+ pump slows down the packing of ATP7B at the TGN into transport vesicles. Cells
that had been treated for 3 h with 100 nM bafilomycin A1 and then with 40 µMCu+ and the drug for the times indicated were stained for ATP7B, TGN38 and EEA1,
and studied by performing microscopy (E–H). Note, the ‘bunch of grapes’ appearance of the cisternae loaded with ATP7B and that the physical segregation of
these cisternae replicates that of the TGN38-positive cisternae (F,G), before breaking down into vesicles that acquire the early endosomemarker EEA1 (H). Areas
indicated with arrows are enlarged in the insets in separate color channels. Scale bars: 10 µm. BF, bafilomycin A1.
2192













microtubules, we incubated Can 10 cells for 15 min with Cu+, to
target the ATP7B retained in the TGN to the basolateral domain,
and then for 60 min at 4°C with the microtubule inhibitor
nocodazole (NOC) before incubation for 40 min at 37°C with or
without NOC and with Alexa-Fluor-647–transferrin, in the
continuous presence of Cu+ (Fig. 5). The results showed that in
cells warmed in NOC, and therefore without microtubules, the
translocation of ATP7B to the apical domain was strongly inhibited
and the protein was retained in numerous vesicles dispersed
throughout the cytoplasm, many of them loaded with transferrin
(Fig. 5B1–B5). In contrast, the washing out of NOC immediately
before warming of the cells resulted in complete reconstruction of
the microtubule network and in translocation of ATP7B to the
apical bile canaliculus (Fig. 5C1–C5).
ATP7B enters the subapical compartment, and brefeldin A
blocks the targeting of ATP7B from the subapical
compartment to the bile canaliculus
Accumulation of ATP7B in the cell apical pole, where the subapical
compartment (SAC) operates as a protein sorting hub (Hoekstra
et al., 2004), occurred within the 15–30-min window after the
addition of Cu+ (Fig. 6A1–A3). This movement was preceded by
the segregation of the ATP7B and transferrin loads (Fig. S2A1–A3),
with transferrin being targeted to the area adjacent to the nucleus,
where clusters of common recycling endosomes recover transferrin
back to the basolateral surface.
Examination of the ATP7B distribution in the apical pole
showed a high degree of coincidence between ATP7B and Rab11a,
the small GTPase associated with the SAC that regulates the
apical transport and recycling of proteins (Welz et al., 2014)
(Fig. 6A1–A3,B). Furthermore, microscopy studies provided
evidence of the transient co-distribution between the two proteins,
consistent with the passage of ATP7B through the Rab11a-
positive SAC before its incorporation into the bile canaliculus
(Fig. 6C1–F3). Separate study of the association of CD63, LIMPII
and LAMP1 with the ATP7B transiting through the SAC in cells
that had been incubated for 25 min with 40 µM Cu+ showed no
evidence of association (Fig. 3C2,D2,E2; statistics are given in
Table S7), and analysis of the experimental data using a geometric
distribution that allows the estimation of the probability to detect
one LIMP signal in the SAC produced a value of pSAC<0.049
(pSAC ¼ 0:033) at a 95% confidence level that strongly endorsed the
experimental observations (Fig. S3B, Table S7).
Transport of ATP7B from the apical pole to the bile
canaliculus is inhibited by the ARF-GEF inhibitor brefeldin A
The fungal toxin brefeldin A (BFA) specifically targets the large
ARFs, GTPases that regulate trafficking pathways by recruiting the
Fig. 2. ATP7B-loaded vesicles are rapidly relocated to the cell basolateral domain after their release from the TGN. Can 10 cells that had been treated
with 40 µM Cu+ for the times indicated were stained for ATP7B (A,B1,B2), the tight junction marker ZO-1 (A) or the marker of the bile canaliculus membrane, HA4
[B1,B2]; nuclei were stained with DAPI. Localization of ATP7B in basolateral endosomes loaded with endocytosed transferrin. Cells were treated for 12 min with Cu+
and with Alexa-Fluor-647–transferrin (Tf) for the last 8 min (C1-C3), or for 25 min with Cu+ and with Alexa-Fluor-647–transferrin for the last 10 min (D1–D3). Arrows
indicate areas enlarged in the insets. Treated cells showed the loading of basolateral endosomes with ATP7B and endocytosed transferrin. Scale bars: 10 µm.
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vesicle coat components AP clathrin adaptors, COPI and GGA
proteins (Cox et al., 2004). Consistent with the localization of
large GEFs in the TGN (BIG1 and BIG2, also known as ARFGEF1
and ARFGEF2) and in endosomes (BIG2), BFA caused the
translocation of ATP7B from the TGN to the apical pole of HepG2
cells (Roelofsen et al., 2000) and created a characteristic patchy
distribution of ATP7B that flanked the bile canaliculi in Can 10 cells
(Fig. S2B1–C3). To study whether the inhibition affected the
translocation of ATP7B from the apical SAC area to the bile
canaliculus, we treated Can 10 cells for 15 min with Cu+ to release
the protein from the TGN, and then for 1 h at 4°C with BFA and
NOC in the presence of Cu+ before raising the temperature to 37°C
and continuing the incubation with the two drugs, with BFA alone
or without drugs (Fig. 6). The results showed that in cells incubated
with NOC and BFA, the ATP7B protein was retained in vesicles
distributed throughout the cytoplasm (Fig. 6G1–G4), whereas the
removal of NOC allowed the advance of ATP7B to the apical area
and its retention in SAC (Fig. 6H1–H4). Moreover, removal of NOC
and BFA resulted in incorporation of ATP7B into the bile
canaliculus (Fig. 6I1–I4). We therefore conclude that BFA
inhibits the transport of ATP7B from the SAC to the bile
canaliculus, probably by inhibiting apical BIG2. Our results were
similar to those described for the transcytosis of the polymeric
immunoglobulin receptor in polarized neurons, where BFA inhibits
the redistribution of the receptor from the basal dendritic domain to
the apical axonal domain (de Hoop et al., 1995). The relocation
of the ATP7B released from the TGN culminated after its arrival at
and incorporation into the bile canaliculus, as shown by its
overlap with the marker of the bile canaliculus membrane HA4
(Fig. 7A1–B3). The whole translocation process required
approximately 60 min (Fig. 7C). Importantly, we never observed
any apically oriented movement of lysosomes during the Cu+-
dependent ATP7B translocation to the bile canaliculus. Moreover,
in three separate studies of the association of CD63, LIMPII and
LAMP1 with the bile canaliculus of cells that had been incubated
for 90 min with 40 µM Cu+, we did not detect any presence of
LIMPs in the bile canaliculus (Fig. 3C3,D3,E3). Analysis of the
experimental data using a geometric distribution produced
pBC<0.019 (pBC ¼ 0:013) at a 95% confidence level, values that
strongly validated the experimental observations (Fig. S3B and
Table S7). With regard to this, it is significant that we never found a
significant incorporation of ATP7B into the lysosomes and of
lysosomal markers into the bile canaliculus of Can 10 or HepG2
cells that had been incubated under stringent Cu+ conditions
(200 µM Cu+ for 24 h) (Fig. S4).
Apical endocytosis and recycling of ATP7B is inhibited by
DYN and BFA, respectively
Treatment of cells with the non-permeable Cu+ chelating agent
bathocuproine disulphonate (BCS) induced only a slow return of
ATP7B from the bile canaliculus to the TGN, probably owing to the
requirement of functional ATP7B in the bile canaliculus to feed
extracellular BCS with excreted Cu+ (Fig. 7D). In contrast, the use
of the cell-permeable Cu+ chelating agent neocuproine (NEC) to
Fig. 3. ATP7B is not incorporated into lysosomes during trafficking through the somatobasolateral domain of Can 10 cells. Reactivity of mouse
monoclonal antibodies with CD63, LIMP II and LAMP1 in Can 10 cells extracts and of rabbit polyclonal antibody with LAMP2 (A). Optical sections from Can 10
cells incubated for 15 min with 40 µM Cu+ and stained for ATP7B and LIMP II are shown in B1–B6; top right, percentage of lysosomes containing ATP7B; bottom
right, optical section number and distance to the plane of cell attachment; nuclei were stained with DAPI. Can 10 cells were incubated for 15, 25 and 90 min with
40 µM Cu+ to compare the cellular distributions of ATP7B and the lysosomal membrane markers CD63, LIMP II and LAMP1 during ATP7B trafficking through the
basolateral domain (C1,D1,E1) and the SAC (C2,D2,E2), and after its incorporation into the bile canaliculus (C3,D3,E3). Scale bars: 10 µm.
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directly reduce intracellular Cu+ produced a more rapid transit and,
after a 2-h incubation with the drug, the bulk of ATP7Bwas returned
to the TGN (Fig. 7D; compare Fig. 7E1–E4 and 7F1–F4). In the
experiments using NEC, we observed that DYN strongly inhibited
the exit of ATP7B from the bile canaliculus, indicating that the
ATP7B was endocytosed by clathrin-coated vesicles (compare
Fig. 7F1–F4 and 7H1–H4). In addition, we also observed that
although organelle de-acidification, induced by bafilomycin A1, did
not inhibit the apical endocytosis of ATP7B, it did inhibit its apical
recycling and return to the TGN, retaining it in large vesicular
bodies that were abundant in the subapical area adjacent to the bile
canaliculus (Fig. 8A1–C4). Because the treatment with BFA
inhibited the targeting of ATP7B to the bile canaliculus
(Fig. 6H1–H4), we studied the possibility that the SAC is
involved in the apical recycling of ATP7B by examining the
distribution of ATP7B in cells that had first been treated with Cu+
for 90 min and then incubated for a further 45 min after the addition
of BFA. The incubation with BFA induced the partial re-
localization of ATP7B from the bile canaliculus to the Rab11a-
positive SAC (compare Fig. 7A1–B3 and 7I1–J3), resulting in the
same patchy peri-canalicular distribution of the apically bound
ATP7B observed in the SAC of cells treated with BFA (compare
Fig. 7I1–J3 with Fig. 6H1–H4 and Fig. S2B1–C3). These results
demonstrate that in cells with elevated levels of Cu+, the ATP7B
transported from the TGN to the bile canaliculus membrane was
continuously endocytosed and cycled between the SAC and the bile
canaliculus.
DISCUSSION
In this study, we have characterized the pathway of ATP7B transport
from the TGN to the bile canaliculus in response to the elevation of
intracellular Cu+ levels in the rat hepatoma cell line Can 10.
The Cu+-induced release of ATP7B from the TGN was found
to be a rapid process that begins within 5 min of the addition of
40 µM Cu+ and is completed within 20–25 min. Treatment with
bafilomycin A1 delayed the detachment of the cisterna carrying
ATP7B from the TGN, demonstrating that cisterna detachment is a
prerequisite to the generation of transport vesicles, as has previously
been described in plants (Uemura et al., 2014). This process is pH
dependent, and the rapidity of this occurrence in mammalian cells is
probably why it has not been previously observed in organisms
other than plants. Our studies also show that the vesicles loaded with
ATP7B budding from the TGN do not contain lysosomal membrane
proteins, suggesting that these are instead segregated into vesicles
distinct from those transporting ATP7B. The ATP7B carriers are
then rapidly transported to a subcellular location in the large
Fig. 4. Basolaterally sorted ATP7B is inserted into the basolateral membrane. DYN blocks transport of ATP7B to the bile canaliculus at the basolateral
membrane. Cells that had been preincubated for 120 min with 100 µM NEC, to confine ATP7B to the TGN, were washed and treated for 60 min with 80 µM
DYN and then for 90 min with 40 µMCu+, in the continuous presence of DYN (A1–A3) or in the absence of DYN for the last 40 min of incubation with Cu+ (B1–B3).
After fixation and permeabilization, the cells were stained for ATP7B, ZO-1 and the basolateral membrane marker β-catenin. Note the accumulation of ATP7B in
the β-catenin-positive basolateral membrane of the cells that had been continuously treated with DYN, and its partial release and arrival to the bile canaliculus after
DYN removal. Transfected HA–ATP7B was inserted into the basolateral membrane and endocytosed (C1–C3). Cells that had been transfected for 11 h with
exofacial-HA-tagged ATP7B were incubated for 3 h in complete Coon’s medium with 50 µg/ml cycloheximide (cyclohex) to inhibit new ATP7B synthesis and for
the last 2 h with 100 µM NEC to retain the bulk of ATP7B in the TGN. The cells were then washed and incubated for 30 min with 100 µM Cu+ and with 2.5 µg/ml
Alexa-Fluor-647–transferrin (Tf ) and 5 µg/ml of monoclonal anti-HA antibody (HA Ab). The fixed and permeabilized cells were studied by performing
immunofluorescencewith specific antibodies to the HA tag and ATP7B. Magnifications of ATP7B, endocytosed Alexa-Fluor-647–transferrin (false blue) and anti-
HA antibody are shown in the insets. Magnified areas are indicated with arrows. Scale bars: 10 µM. (D) Pulldown of ATP7B and the clathrin adaptor AP-2α subunit
(αAP2). Detergent-solubilized postnuclear supernatants from Can 10 cells that had been incubated for 15 min with or without 40 µM Cu+ were incubated with
specific antibodies to either ATP7B or the α-subunit of the AP-2 clathrin adaptor directly bound to Protein-G–Sepharose (Prot G). The immunoprecipitates were
subjected towestern blot analyses (W) using antibodies against the pulled down proteins. Controls included analysis of the total cell extracts (INPUT) andmaterial
precipitated by Protein-G–Sepharose alone (Prot G). The results show the reciprocal immunoprecipitation of ATP7B (*) and the AP-2 α-subunit (**) and the
amounts of the AP-2α subunit pulled down by the ATP7B antibody from extracts of cells incubated in the absence or presence of Cu+. IP, immunoprecipitation.
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basolateral domains of Can 10 cells, directly opposite the apical
domains where the bile canaliculi are located. The basolateral
sorting of ATP7B at the TGN can be explained by the Cu+-mediated
interaction of the C-terminal sequence motif DKWSLLL with the
clathrin adaptor AP-1A complex that is resident in the TGN (Lalioti
et al., 2014) because this adaptor operates in the basolateral sorting
of membrane proteins in hepatocytes that lack AP-1B (Gravotta
et al., 2012). The role of AP-1A in the basolateral sorting and
recovery of ATP7B from endosomes to the TGN (Braiterman et al.,
2011) explains why mutations in σ1A, the small subunit of the AP-1
adaptors, produce severe perturbations of copper ion metabolism in
humans (Martinelli et al., 2013).
Our detection of basolaterally endocytosed transferrin in the
ATP7B vesicular carriers that were localized at the distal end of
the basolateral domain suggests that ATP7B is transported by
basolateral endosomes and/or endocytic vesicles. This suggestion is
supported by recent studies demonstrating that de-acidification of
the luminal pH results in the trapping of ATP7B in aggregates of
EEA1-positive endosomes that are localized to the basolateral
domain of polarized WIF-B cells (Nyasae et al., 2014).
Furthermore, the colocalization of both endocytosed anti-HA
antibody and Alexa-Fluor-647–transferrin in the basolateral
endosomes of cells that had been transfected with HA-tagged
ATP7B and incubated for 30 min with Cu+ indicates that
basolaterally sorted HA–ATP7B is first inserted into the
basolateral membrane and is then subsequently endocytosed. This
notion is supported by the observed accumulation of ATP7B in the
basolateral membrane of cells that had been treated with DYN, an
inhibitor of both dynamin and clathrin-mediated endocytosis, and
the concomitant reduction in the incorporation of the ATP7B into
the bile canaliculus, and is consistent with the mutual pulldown of
ATP7B and the α-subunit of the clathrin adaptor AP-2, which is
implicated in endocytosis. With respect to the movement of ATP7B
from the basolateral to the apical domain, it is interesting that
ATP7B contains an FAFDNVGYE signal motif, a variant of the
[FY]XNPX[YF] signal that is recognized by the basolateral
retromer and absent in ATP7A (Donoso et al., 2009), which is
essential for the apical targeting of ATP7B in elevated-Cu+
conditions and mediates the retention of the transporter in the
TGN at low-Cu+ concentrations (Braiterman et al., 2009).
The accumulation of ATP7B in the SAC of cells that had been
incubated with BFA following endocytosis of the protein from the
basolateral membrane, together with its incorporation into the bile
canaliculus after removal of the drug, implicate the involvement of a
large ARF-GEF that is localized in recycling endosomes, such as
BIG2, in the targeting of ATP7B from the SAC to the bile
canaliculus. Our finding that BFA inhibits the recycling of apically
endocytosed ATP7B to the bile canaliculus by retaining the protein
Fig. 5. ATP7B transcytosis requires
microtubules. Can 10 cells were incubated for
60 min at 4°C with 20 µM NOC and then for
40 min at 37°C with both NOC and Alexa-Fluor-
647–transferrin (Tf ) (A1–A3), or incubated for
15 min with 40 µM Cu+, to release the ATP7B
retained in the TGN, followed by incubation with
NOC and Alexa-Fluor-647–transferrin in the
presence of Cu+ (B1–B3). Microtubules were
reconstituted by washing out the NOC and
performing the last incubation with Cu+ and
Alexa-Fluor-647–transferrin in the absence of
the drug (C1–C3). All cells were stained for
ATP7B, TGN38 and microtubules (tubulin).
Panels on the right-hand side (A4, A5, B4, B5,
C4, C5) show magnifications of the areas
indicated with arrows. Scale bars: 10 µm.
Notice the retention of ATP7B in vesicles after
its release from the Golgi and the disruption of
microtubules, and the resumption of the ATP7B
transport to the apical bile canaliculus after
reassembly of microtubules.
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in the SAC suggests that the same mechanisms of transport that
operate in the SAC could function in both the transcytosis of ATP7B
and in its apical recycling.
The inhibition of apical ATP7B endocytosis by DYN is
consistent with the bile canaliculus being the site of ATP7B
function in Cu+ excretion. It should be noted that this finding
confirms previous observations of Cu+-induced translocation of
ATP7B from the TGN to the bile canaliculus in HepG2 cells
and the localization of ATP7B in the bile canaliculus of liver
(Guo et al., 2005; Roelofsen et al., 2000; Schaefer et al., 1999b),
and that these studies have been subsequently confirmed in other
cells by other laboratories (Guo et al., 2005; Hernandez et al.,
2008).
It is intriguing to note that although most of the membrane
proteins resident in the bile canaliculus that contain multiple
transmembrane-spanning sequences are directly targeted from the
Golgi (Kipp and Arias, 2002), ATP7B in contrast uses a distinct
transcytosis route to reach the bile canaliculus, a route that was
previously thought to be restricted to apical proteins with a single
transmembrane domain (Bastaki et al., 2002).
The conclusions of the studies reported here are in contrast with
those of a recent study in HepG2 cells that proposes that ATP7B is
rapidly and directly targeted from the TGN to lysosomes in response
to Cu+ and that fusion of the Cu+-loaded lysosomes with the bile
canaliculus membrane results in the excretion of excess Cu+ into the
bile (Polishchuk et al., 2014). The latter studies extend previous
reports that interpret the presence and functioning of transfected
GFP–ATP7B and ATP7B–DsRed constructs in late endosomes as
part of the lysosome-mediated excretion of Cu+ into the bile. In
those studies, the ATP7B constructs were not detected in the TGN
and were not relocated in response to excess Cu+ (Harada et al.,
2005, 2003b, 2000a,b). In contrast, in our studies in highly
polarized Can 10 cells, we observe that excess Cu+ induces the rapid
translocation of endogenous ATP7B from the TGN to the bile
canaliculus by basolateral sorting and transcytosis. Moreover,
during this rapid trafficking process, we did not find any association
of ATP7Bwith lysosomes and, repeating these studies using HepG2
cells, we could not find any ATP7B in the lysosomes in response to
treatment with Cu+ in these cells. Furthermore, we did not observe
any Cu+-induced movement of lysosomes towards the bile
Fig. 6. Apically bound ATP7B transits through the SAC compartment.Can 10 cells were treated for 25 min with 40 µMCu+ and stained for ATP7B and for the
SAC marker Rab11a (A1–A3); notice the characteristic two- and three-leaved arrangement of the SACs, SACs indicated with arrows are magnified in the insets.
Scale bars: 10 µm. Pearson’s andManders’ co-distribution coefficients (co-distribution tends to 1; median±Sw0.2) were computed using 17 confocal SAC images,
and the Fiji Coloc 2 and JACoP software (B); observe the high degree of ATP7B and Rab11a co-distribution. Passage of ATP7B through the SAC was studied in
cells that had been incubated for 25 min with 40 µM Cu+ to record the ATP7B approach (C1–C3) and entrance into the SAC (D1–D3), and its subsequent
incorporation into the inner circular bile canaliculus (E1–F3). Note the different rates of ATP7B entry in the SAC. Scale bars: 5 µm (C1–F3). Transport of ATP7B
from the SAC to the bile canaliculus is inhibited by BFA. Can 10 cells were incubated for 15 min with 40 µM Cu+ and then for 60 min at 4°C after the addition of
10 µg/ml BFA and 20 µg/ml NOC, before removal of BFA (G1–G4), NOC (H1−H4) or BFA and NOC (I1-I4), which was followed by incubation for 40 min with Cu+
at 37°C. Cells were stained for ATP7B, ZO-1 and TGN38 as indicated. Panels on the right-hand side (G3, G4, H3, H4, I3, I4) show magnifications of the areas
indicated with arrows. Scale bars: 10 µm. Notice the resumption of transport of the apically bound ATP7B after removal of NOC and the retention of ATP7B in the
SAC of cells incubated with BFA (see also Fig. S2), as well as the translocation of ATP7B from the SAC to the bile canaliculus after removal of BFA.
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canaliculus, nor did we detect any incorporation of four
distinct LIMPs into the bile canaliculus, as would be expected
if the excretion of Cu+ was primarily mediated by lysosomal
exocytosis.
The picture emerging from studies in human and frozen sections
of rat liver is that endogenous ATP7B is localized in the TGN and in
the bile canaliculus (Schaefer et al., 1999a,b). However, more
studies are needed to establish the response of the ATP7B that is
retained in the TGN to excess Cu+ in liver.
It is important that abnormal intracellular trafficking of the Cu+
transporters has been detected in multisystemic diseases that present
with symptoms like those of Menkes and Wilson diseases. The
transport of ATP7B from the TGN to the bile canaliculus through
basolateral sorting and transcytosis explains that two of those
Fig. 7. ATP7B incorporation into the bile canaliculus, DYN-sensitive apical endocytosis and BFA-sensitive apical recycling. ATP7B incorporation into
the bile canaliculus was studied in cells with long and short bile canaliculi that had been treated for 90 min with 40 µM Cu+, and stained for ATP7B and ZO-1
(A1–A3) and the bile canaliculus membrane marker HA4 (B1–B3). Notice the retention of ATP7B in the bile canaliculus that is boxed and sealed by the ZO-1-
positive tight junctions, and the co-localization of ATP7B with the apical membrane marker HA4; ATP7B-loaded apical endosomes are marked with an asterisk.
Time course of the Cu+-dependent ATP7B relocation from the TGN to the bile canaliculus. Cells were fixed and permeabilized after incubation with 40 µMCu+ for
the indicated times were stained for ATP7B, TGN38, Rab11aA and HA4 (C); single organelles (TGN, SAC, bile canaliculus) and basolateral vesicles were
counted in 50 cells per time point [(median±winsorized standard deviation (Sw0.2)]. The experiment shown is representative of three experiments. ATP7B apical
endocytosis and retrograde transport to the TGN. Cells that had been preincubated for 90 min with Cu+ were incubated after washing out Cu+ with 100 µM of the
cell-permeable and impermeable Cu+-chelating agents NEC and BCS, respectively, for the times indicated (D); notice that the action of NEC was strongest.
Incubation with NEC induced the complete translocation of ATP7B to the TGN after 120 min of incubation (D; compare E and F). *P<0.05, **P<0.01, ***P<0.001
(Student’s t-test). ATP7B apical recycling and retrograde transport. Apical ATP7B endocytosis was studied in Can 10 cells that had been incubated for 90 min with
40 µM Cu+ and then for 60 min with 80 µM DYN and Cu+ (G1–G4), before removal of Cu+ and incubation for 2 h with DYN and 100 µM NEC (H1–H4); treatment
showed the strong inhibition of ATP7B apical endocytosis by the dynamin inhibitor DYN. Apical recycling of endocytosed ATP7B. Recycling was studied in cells
that had been incubated for 90 min with 40 µMCu+ and then for a further 45 min with 10 µg/ml BFA in the presence of Cu+; compare panels I1–J3 with panels A1–
B3 and notice the retention of ATP7B in the RAb11a-positive SAC, flanking the tight junctions, of the BFA-treated cells. Arrows in the inset of I indicate the
association of a pool of ATP7B with the tight junctions, and asterisks in I indicate the SAC. Scale bars: 10 µm.
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multisystemic diseases are produced by mutations that target AP-1A
(Martinelli et al., 2013), the clathrin adaptor resident in the TGN that
is implicated in the basolateral sorting of protein in the hepatocyte
(Gravotta et al., 2012), and COMMD1 (van De Sluis et al., 2002),
the component of the CCC complex that in cooperation with the
WASH complex and the retromer regulates the trafficking of cargo
through basolateral endosomes in polarized cells and is required for
transcytosis (Phillips-Krawczak et al., 2015; Verges et al., 2004).
These observations emphasize the importance of elucidating the
mechanisms that regulate the trafficking of Cu+ transporters in order
to facilitate diagnoses, and to understand the development and
prognosis of Cu+ disorders.
In closing, this study describes that the Cu+-dependent relocation
of ATP7B from the TGN to the bile canaliculus includes basolateral
sorting at the TGN, and transport to and endocytic retrieval at the
basolateral membrane, which is followed bymicrotubule-dependent
transcytosis through the SAC and incorporation into the bile
canaliculus. These results indicate that the site of ATP7B action in
vectorial Cu+ excretion is the membrane of the bile canaliculus.
MATERIALS AND METHODS
Cell culture
Rat hepatoma Can 10 and human hepatoma HepG2 cells were grown in
Coon’s modification medium supplemented with 1.5 g/l NaCO3H, 10%
fetal calf serum, 1% glutamax, penicillin and streptomycin. Can 10 cells
were cultured for 5 days for complete surface polarization, and medium was
changed daily. Counting of basolateral vesicles was facilitated by growing
the Can 10 cells on poly-lysine-coated coverslips and incubating the cells
for 10 h in Coon’s medium supplemented with 0.5 mM 3-isobutyl-1-
methylxanthine.
cDNA cloning, constructs and transfections
Mouse ATP7B cDNA was cloned by PCR amplification of a mouse liver
Marathon Ready cDNA library (Lalioti et al., 2014). Exofacial HA-tagging
of ATP7Bwas performed by introducing the tag into the third exofacial loop
of ATP7B (Lalioti et al., 2014). Cells were transfected for 11 h using
Lipofectamine 2000 to avoid protein overexpression and incubated with
50 µg/ml cycloheximide for the final 3 h to inhibit new ATP7B synthesis.
Antibodies
Polyclonal anti-ATP7B antibodies were developed in rabbit and rat against
the entire N-terminal cytoplasmic domain of the protein (Hernandez et al.,
2008). The following antibodies were also developed in our laboratory:
Mouse monoclonal and rabbit polyclonal antibodies against TGN38 (Yuan
et al., 1987), rabbit polyclonal anti-LAMP2 antibody and mouse
monoclonal antibodies against lysosomal integral membrane proteins
CD63 (LIMP1), LIMPII and LAMP1 (LIMPIII) (Barriocanal et al.,
1986), and rabbit polyclonal against LAMP2. Monoclonal antibodies
against the apical marker HA4 (c19) and the tight junction protein ZO-1
(R26.4C) were developed by Drs A. Hubbard (Johns Hopkins University,
MD) and D. A. Goodenough (Harvard Medical School, MA), respectively,
and were obtained from the Developmental Studies Hybridoma Bank,
created by the NICHD of the NIH andmaintained at The University of Iowa,
Department of Biology, Iowa City, IA 52242. Other antibodies used were:
mouse monoclonal anti-HA clone 16B12 (Covance, CA; catalogue number
MMS-101P); mouse IgG1 anti-β catenin and anti-EEA1 (BD Biosciences,
Fig. 8. Bafilomycin A1 blocks ATP7B apical recycling and retrograde transport to the TGN. Can 10 cells that had been first incubated for 90 min with 40 µM
Cu+ to induce the translocation of ATP7B to the bile canaliculus (A1–A4) were then incubated for 3 h with 60 nM bafilomycin A1 and Cu+ (B1–B4) and, after
washing out of Cu+, were incubated for 2 h with bafilomycin A1 and 100 µM NEC (C1–C4). The cells that had been treated with bafilomycin A1 in the presence of
Cu+ showed the accumulation of ATP7B in vesicular bodies that were distinct from bile canaliculus and TGN (compare A and B, arrows), and bafilomycin A1 (BF)
blocked the retrograde transport of ATP7B to the TGN after removal of Cu+ through NEC treatment (C1, arrows). The intensity of fluorescence of ATP7B in the bile
canaliculus (D) and TGN (E), and size of ATP7B-positive vesicular bodies (F) were quantified. Data collected from 20 bile canaliculi and 50 TGN in three randomly
selected fields (mean±s.d.); **P<0.01, ***P<0.001 (Student’s t-test). Scale bars: 5 µm.
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catalogue numbers 610154 and 610546); mouse monoclonal anti-Rab 11a
(Abcam, UK; cat. 78337); rat monoclonal YOL 1/34 anti-tubulin (Sigma
Aldrich, MO; catalogue number CBL270): Goat anti-α adaptin (Santa Cruz
Biotech.; catalogue number 6422). Specific antibodies were used at 1:600
and 1:1000 dilutions in immunofluorescence microscopy and western
blotting studies, respectively Alexa-Fluor-488-, Alexa-Fluor-647- and
Pacific-Blue-conjugated secondary antibodies and Alexa-Fluor-647-
conjugated transferrin were from Life Technologies.
Chemicals
Neocuproine (NEC), bathocuprine disulfonate (BCS) and brefeldin A
(BFA) were from Sigma-Aldrich; nocodazole (NOC) and dynasore (DYN)
and chloroquine (CQ) were from Santa Cruz Biotech; Bafilomycin A1 was
from Shelleckchem.
Immunofluorescence microscopy
Cell fixation was adapted to antibody reactivity; fixation and
permeabilization was performed by treatment with cold (−20°C)
methanol for 4 min [for antibodies against ATP7B, ZO-1, YOL 1/34
(tubulin), TGN38, β-catenin, CD63, LIMPII, LAMP1 and LAMP2], for
20 min with 2% paraformaldehyde and 5 min with 0.2% Triton X-100 [for
antibodies against ATP7B, ZO-1, Rab11a, YOL 1/34 (tubulin), HA tag and
EEA1] or for 1 min with 3% paraformaldehyde and 10 min with methanol at
5°C (for antibodies against ATP7B, ZO-1, HA4). All antibodies were
diluted 1:300 in PBS containing 0.2% bovine serum albumin.). For
colocalization studies, cells were grown on 0.1–0.16-mm glass coverslips
and mounted in gelvatol (refractive index 1.376). Stable Alexa-Fluor-488
and Alexa-Fluor-647 dyes were used to avoid spectral bleed, and the stained
cells were examined using a Zeiss Plan apochromat ×63 NA1.4 oil DIC
objective and oil with a refractive index of 1.51. Capture Images were de-
convoluted and studied using Coloc 2 and JACoP modules of ImageJ
software. Data were subjected to robust statistical analyses.
ATP7B trafficking assays
The de-acidification agent bafilomycin A1, the dynamin inhibitor DYN,
the microtubule inhibitor NOC, the ARF-GEF inhibitor BFA and
incubation at low temperature were used to treat cells and help dissect
the pathway of transport. Translocation of ATP7B from the TGN to the
bile canaliculus was studied by challenging Can 10 cells with 40 µM Cu+
for periods between 5 min and 2 h; the translocation process was best
monitored in small islets of highly polarized cells. The effective retention
of ATP7B in the TGN at 0.3 µM Cu+ made unnecessary the use of Cu+-
chelating agents to start protein trafficking of ATP/B with most of it in the
TGN. In a set of trafficking experiments, we established as landmarks of
the ATP7B anterograde traffic, the beginning (5–7 min) and completion
(10–20 min) of its release from the Golgi, its appearance in basolateral
endosomes loaded with endocytosed transferrin (8–20 min), its approach
and entrance into the SAC (15–35 min), and its incorporation into the bile
canaliculus (30 min–1 h) (see Fig. 7C). These landmarks helped to set a
series of traps to dissect the pathway of ATP7B transport: bafilomycin A1
and chloroquine were employed to slow down the release of ATP7B by
acidic vesicles from the TGN; DYN, the inhibitor of dynamin and clathrin-
dependent endocytosis, was used at 80 µM in serum-free medium to
examine the trafficking of ATP7B through the basolateral membrane;
NOC, the microtubule-depolymerizing agent, was a powerful tool to study
the second leg of trafficking between the basolateral membrane and the
SAC, and the incorporation of ATP7B into the bile canaliculus; we
incubated cells for 15 min with Cu+ to target ATP7B from the TGN to
basolateral endosomes, and then for 1 h with Cu+, NOC and BFA at 4°C
to disrupt the microtubules and to set the stage to study the redistribution
of basolateral ATP7B after warming the cells in the absence of NOC, and
the presence or absence of BFA; the trapping of ATP7B in the SAC of
cells that had been warmed in the absence of NOC and in the presence of
BFA helped to characterize the passage of ATP7B through the SAC and
indicated the involvement of a BFA-sensitive ARF-GEF in the regulation
of ATP7B targeting from the SAC to the bile canaliculus, probably apical
BIG2; for studies of apical ATP7B endocytosis and retrograde transport,
the cell permeable agent NEC was the Cu+-chelating agent of choice
because it quickly elicits the backwards trafficking of ATP7B in response
to decreased Cu+ levels, the cell-impermeable agent BCS was less
effective; DYN was a powerful tool to study the apical endocytosis of
ATP7B in cells that had been deprived of Cu+ through treatment with
NEC, whereas BFA was effective in trapping the apically endocytosed
ATP7B in cells that had been continuously incubated with Cu+. The
experiments were repeated an average of three times.
Immunoprecipitation and western blot studies
All the procedures were performed at 4°C. Can 10 cells were washed twice
with TBS, scraped, suspended in 1 ml of cold buffer A [20 mM HEPES
pH 7.5, 130 mM NaCl, 1 mM EGTA and 5.5 mg of the cocktail of
protease inhibitors Complete Mini (Roche)] and incubated in 1% NP40 for
10 min. Nuclei were removed by centrifugation at 100 g for 10 min. The
resulting post-nuclear supernatant was incubated at 4°C for 1 h, aggregates
were removed by centrifugation at 15,000 g for 10 min, and the
supernatant was diluted using buffer A to a final concentration of 0.6%
NP40. Equal aliquots of extract were separately incubated for 4 h with the
rabbit anti-ATP7B antibody (dilution 1:300 in PBS containing 0.2%
bovine serum albumin) or the goat anti-AP-2α antibody (dilution 1:300 in
PBS containing 0.2% bovine serum albumin.) bound to Protein-G–
Sepharose, prepared by mixing 5 μl of each antibody with 15 μl of
Protein-G–Sepharose (GE Healthcare) and then washing off excess
antibody. Immunoprecipitation complexes were collected by low-speed
centrifugation and, after three washes in buffer A and one in water, were
resuspended and heated (85°C, 3 min) in Laemmli buffer and resolved by
performing 10% SDS-PAGE. The resolved proteins were blotted onto
nitrocellulose and studied using bioluminescence, donkey anti-rabbit
horseradish peroxidase (HRP)-conjugated (GE Healthcare) and donkey
anti-goat HRP-conjugated (Merck Millipore) antibodies, and the Clean
Blot IP detection kit (Thermo Scientific). The ATP7B–AP-2α pulldown
experiment was repeated twice.
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